Super Lightening Based On Gold 24k And Kojic Acid Cream

Papaya (Carica papaya) is utilized in clinical settings primarily as a non-standardized food allergenic extract for diagnostic testing. It belongs to the class of Non-Standardized Food Allergenic Extracts used to identify IgE-mediated sensitivities.

Dosage for Papaya as an allergenic extract is not standardized by weight or volume in the same way as traditional medications. Instead, it is based on the concentration of the extract and the method of administration.

• Skin Prick Testing (SPT): A single drop of a 1:20 w/v (weight to volume) or 1:10 w/v extract is applied to the skin (usually the forearm or back). A sterile lancet is then used to prick the skin through the drop. The result is read 15 to 20 minutes later.
• Intradermal Testing: If the skin prick test is negative but a high clinical suspicion of allergy remains, a healthcare provider may inject 0.02 mL of a much more dilute solution (e.g., 1:1000 or 1:100) into the dermis. This carries a higher risk of systemic reaction.
• Oral Enzyme Supplements: Common doses for papain-based supplements range from 50 mg to 500 mg per meal, though these are not FDA-standardized for medical treatment.

Papaya allergenic extracts can be used in children, but the procedure must be performed with extreme caution.

• Infants and Children: The dosage (the amount applied during a skin test) is the same as adults, but the number of tests performed at one time is often limited to reduce the risk of systemic reactions.
• Safety: Testing is generally avoided in children with severe, uncontrolled asthma, as they are at higher risk for severe reactions to the test itself.

Renal Impairment

No specific dosage adjustments are required for renal impairment due to the minimal systemic absorption of the diagnostic extract. However, patients with end-stage renal disease may have altered skin reactivity (uremic pruritus), which can make skin test results difficult to interpret.

Hepatic Impairment

No dosage adjustments are necessary for patients with liver disease. The metabolic load of a diagnostic skin test is negligible.

Elderly Patients

In patients over 65, skin reactivity may be diminished. Healthcare providers may need to use a stronger positive control (histamine) to ensure the skin is capable of mounting a response before interpreting a negative papaya test.

For Diagnostic Testing

1. 1Preparation: You must stop taking antihistamines (e.g., diphenhydramine, cetirizine, loratadine) for at least 3 to 7 days before the test, as these will block the allergic response and lead to a false-negative result.
2. 2Administration: The test is performed in a clinic. The skin is cleaned with alcohol, the extract is applied, and the skin is pricked.
3. 3Observation: You must remain in the clinic for at least 30 minutes after the test to be monitored for signs of a systemic allergic reaction (anaphylaxis).

For Oral Supplements

• Timing: Take with or immediately after meals to aid in protein digestion.
• Swallowing: Tablets should be chewed or swallowed as directed on the label. Do not exceed the recommended daily intake.

For diagnostic testing, a missed appointment simply means the test must be rescheduled. For oral supplements, if you miss a dose with a meal, take it as soon as you remember during or shortly after the meal. If it is almost time for your next meal, skip the missed dose. Do not double the dose.

Signs of Overdose (Systemic Reaction)

• Generalized hives or itching
• Swelling of the lips, tongue, or throat
• Difficulty breathing or wheezing
• Rapid drop in blood pressure (fainting or dizziness)
• Nausea, vomiting, or abdominal cramping

Emergency Measures

In the event of an overdose or systemic reaction during testing, the healthcare provider will immediately administer epinephrine (EpiPen) and may provide oxygen, intravenous fluids, and antihistamines. If an overdose of oral supplements occurs, contact a Poison Control Center, though the primary risk is gastrointestinal upset.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt self-testing without medical guidance.

When Papaya is used as an allergenic extract for skin testing, localized reactions are the most common and, in fact, the intended effect for a positive diagnosis.

• Localized Wheal and Flare: A raised, itchy bump (wheal) surrounded by redness (flare) at the site of the test. This typically appears within 15 minutes and subsides within 1 to 2 hours.
• Pruritus (Itching): Intense itching at the test site is very common and can be managed with a topical corticosteroid or oral antihistamine after the test has been read.
• Local Irritation: Mild soreness or tenderness where the skin was pricked.

Papaya allergenic extract is intended solely for diagnostic use by clinicians experienced in the management of allergic diseases. It is not for therapeutic injection. Because of the risk of severe systemic reactions, including anaphylaxis, the extract should only be used in settings equipped with emergency resuscitative equipment, including epinephrine, oxygen, and airway management tools. Patients should be informed that a positive skin test does not always correlate with a clinical allergy; the results must be interpreted in the context of the patient's medical history.

No FDA black box warnings for Papaya allergenic extracts. However, clinicians are cautioned that non-standardized extracts have variable potency, and extreme care must be taken when switching between different manufacturers or lots of the extract.

• Allergic Reactions / Anaphylaxis Risk: The most significant risk is a systemic allergic reaction. This is more likely in patients with high levels of specific IgE or those who have had previous severe reactions to papaya or cross-reactive substances like latex, kiwi, or avocado.

There are few absolute contraindications for drug combinations, but the following must be avoided to ensure safety and accuracy:

• Beta-Blockers (e.g., Propranolol, Atenolol): Patients taking beta-blockers may be resistant to the effects of epinephrine. If a patient on a beta-blocker has an anaphylactic reaction to a papaya skin test, the standard treatment (epinephrine) may be ineffective, leading to a potentially fatal outcome. Many allergists consider beta-blocker use a relative or absolute contraindication for skin testing.

• ACE Inhibitors (e.g., Lisinopril, Enalapril): These medications can interfere with the body's ability to degrade kinins, potentially making an allergic reaction more severe or prolonged.
• Tricyclic Antidepressants (e.g., Amitriptyline)

Papaya allergenic extract must NEVER be used in the following circumstances:

• Previous Severe Anaphylaxis to Papaya: If a patient has a history of a life-threatening reaction to papaya, skin testing may be too dangerous. In such cases, an in vitro (blood) test for IgE is preferred.
• Uncontrolled Asthma: Patients with a Forced Expiratory Volume in 1 second (FEV1) of less than 70% of predicted, or those with frequent exacerbations, are at extreme risk of death from a systemic reaction during testing.
• Dermatographism: This is a condition where the skin becomes raised and red with even minor stroking. In these patients, the skin test will always appear 'positive' regardless of whether an allergy exists, making the test useless.

Pregnancy Category: Not Classified. There are no adequate and well-controlled studies of papaya allergenic extract in pregnant women. Most allergists recommend avoiding skin testing during pregnancy because of the risk of systemic anaphylaxis, which can lead to uterine contractions, placental hypoperfusion, and fetal distress. If a diagnosis is essential, blood testing (IgE ImmunoCAP) is the safer alternative as it poses no risk of a systemic reaction to the mother or fetus.

It is not known whether components of papaya allergenic extract are excreted in human milk. However, because the amount used in skin testing is so small and systemic absorption is minimal, it is generally considered unlikely to affect a nursing infant. Nevertheless, the decision to test should be made after discussing the risks and benefits with a healthcare provider.

Skin testing with papaya extract is common in the pediatric population to investigate food allergies.

Papaya allergenic extract contains various proteins, the most significant being papain (Carica papaya allergen 1). In the context of an allergy, these proteins act as antigens. When introduced into the skin of a sensitized individual, these antigens cross-link specific IgE antibodies bound to the surface of mast cells and basophils. This cross-linking triggers a signal transduction cascade involving tyrosine kinases, leading to the release of pre-formed mediators like histamine and the de novo synthesis of leukotrienes and cytokines. These substances cause the classic allergic 'wheal and flare' response.

• Onset: The localized allergic response typically begins within 5 minutes of administration.
• Peak Effect: The wheal and flare reaction usually reaches its maximum size between 15 and 20 minutes.